Related Experiment Videos
Endotoxin, tumor necrosis factor, and related mediators: new approaches to shock
1Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas.
New Horizons (Baltimore, Md.)
|February 1, 1993
Abstract:
For some time, it has been clear that septic shock results from the coordinated release of cytokine mediators that directly or indirectly injure tissues of the host. Natural and synthetic inhibitors of tumor necrosis factor, interleukin-1, and other key cytokines may alter current concepts regarding shock and its therapy.
Insights
Septic shock involves cytokine mediators that harm host tissues. Inhibitors of tumor necrosis factor and interleukin-1 may change how we treat septic shock.
Area of Science:
- Immunology
- Pathophysiology
- Pharmacology
Background:
- Septic shock is a complex condition characterized by the release of cytokine mediators.
- These mediators contribute to host tissue injury during septic shock.
Purpose of the Study:
- To explore the potential of cytokine inhibitors in altering the understanding and treatment of septic shock.
Main Methods:
- Review of existing literature on cytokine mediators in septic shock.
- Analysis of natural and synthetic inhibitors of key cytokines, including tumor necrosis factor and interleukin-1.
Main Results:
- Cytokine mediators play a central role in the pathophysiology of septic shock.
- Inhibitors targeting these cytokines show promise in modulating the shock response.
Conclusions:
- Targeting cytokine mediators represents a potential therapeutic strategy for septic shock.
- Further research into cytokine inhibitors could revolutionize septic shock therapy.